Martin Schultz Selected Research

Martin Schultz Research Topics

4	Neoplasms (Cancer) 01/2021 - 04/2012
3	Endocarditis 12/2022 - 01/2019
3	Heart Arrest (Cardiac Arrest) 01/2022 - 03/2021
2	Inflammation (Inflammations) 06/2020 - 03/2019
1	Infections 12/2022
1	COVID-19 01/2022
1	Breakthrough Infections 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Sarcopenia 12/2020
1	ST Elevation Myocardial Infarction 06/2020
1	Bacteremia 01/2019
1	Weight Loss (Weight Reduction) 01/2017
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2017
1	Frailty 09/2016
1	Hemorrhage 01/2013
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 04/2012

5	Biomarkers (Surrogate Marker)IBA 12/2020 - 01/2017
3	Anti-Bacterial Agents (Antibiotics)IBA 12/2022 - 01/2019
3	Vasopressins (Vasopressin)IBA 01/2022 - 03/2021
3	Methylprednisolone FDA LinkGeneric 01/2022 - 03/2021
3	Urokinase Plasminogen Activator ReceptorsIBA 10/2020 - 01/2017
1	COVID-19 VaccinesIBA 01/2022
1	BNT162 VaccineIBA 01/2022
1	Epinephrine (Adrenaline)FDA LinkGeneric 01/2022
1	VaccinesIBA 01/2022
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 06/2020
1	CoagulaseIBA 01/2019
1	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 01/2017
1	C-Reactive ProteinIBA 01/2017
1	Pattern Recognition ReceptorsIBA 01/2017
1	ofatumumab FDA Link 04/2012
1	Rituximab (Mabthera)FDA Link 04/2012

2	Drug Therapy (Chemotherapy) 01/2021 - 04/2012
2	Length of Stay 09/2016 - 01/2013
1	Resuscitation 01/2022
1	Drug Tapering 01/2021
1	Percutaneous Coronary Intervention 06/2020
1	Polypharmacy 09/2016
1	Laparotomy 01/2013
1	Therapeutics 04/2012